JSM2025
Back to all people

Yongming Qu

Eli Lilly and Company
6 appearances in the program

Sessions & presentations

Statistical Innovation and Opportunities for Oncology Clinical Trials
Presentation: A Framework for Designing and Modeling Combination Dose Response Studies
Contributed Papers · Mon, Aug 4 , 8:30 AM
Co-Author
Navigating Estimands and Missing Data: Emerging Trends in Clinical Development
Presentation: Missing data sensitivity analysis for binary outcomes derived from underlying continuous variables
Contributed Papers · Tue, Aug 5 , 2:00 PM
Co-Author
Leveraging Generative AI and Transfer Learning in Healthcare - Opportunities and Challenges
Presentation: Efficiency Enhancement in Clinical Trials: Leveraging NLP for Automated Outcome Adjudication
Invited Paper Session · Tue, Aug 5 , 10:30 AM
Co-Author
SPEED 5: Causal inference, Precision Medicine and Clinical Trials, Part 1
Presentation: Evaluating the Heterogeneity of Treatment Effects Across Subgroups with Existance of Missing Data
Contributed Speed · Tue, Aug 5 , 8:30 AM
Co-Author